BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2442904)

  • 1. [The Pancreas Study Group: Inhibition of pancreas secretion and trypsin activity. Mechanisms and importance of therapy of acute and chronic pancreatitis].
    Z Gastroenterol Verh; 1987 Apr; 22():132-55. PubMed ID: 2442904
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.
    Niederau C; Liddle RA; Ferrell LD; Grendell JH
    J Clin Invest; 1986 Oct; 78(4):1056-63. PubMed ID: 2428840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin analogue and cholecystokinin receptor antagonist on bile-induced acute canine pancreatitis.
    Ko TC; Bertram MF; Prinz RA; Castelli M; Djuricin G; Jacobs HK
    Am Surg; 1992 Apr; 58(4):213-9. PubMed ID: 1375011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic pancreatitis. Symptoms, laboratory diagnosis and conservative treatment].
    Rick W
    Chirurg; 1968 Jul; 39(7):301-6. PubMed ID: 5703768
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
    Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
    Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secretory pattern of the pancreas in chronic pancreatitis].
    Otte M; Thurmayr GR; Thurmayr R
    Z Gastroenterol; 1989 Dec; 27 Suppl 3():35-7. PubMed ID: 2483477
    [No Abstract]   [Full Text] [Related]  

  • 8. Reproducibility of the response to secretin and secretin plus pancreozymin in man.
    Tympner F; Domschke S; Domschke W; Classen M; Demling L
    Scand J Gastroenterol; 1974; 9(4):377-81. PubMed ID: 4854120
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis].
    Ohnishi H; Kosuzume H; Ashida Y; Kato K; Suzuki Y; Honjo I
    Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):235-44. PubMed ID: 6345304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of protease inhibitors on the activity of trypsin and lipase in the pancreas and blood serum of rats in acute pancreatitis].
    Khudoley IF; Levitsky AP; Synovets AS
    Vopr Med Khim; 1975; 21(3):296-9. PubMed ID: 1210107
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of anti-enzyme therapy on the exocrine function of the pancreas in chronic pancreatitis].
    Golubchenko OK; Revutskiĭ BI
    Vrach Delo; 1971 Jan; (1):39-42. PubMed ID: 5314100
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of thyroidectomy on pancreatic exocrine secretion.
    Kaynan A; Ben-Ari GY; Dreiling DA
    Am J Gastroenterol; 1973 Apr; 59(4):336-9. PubMed ID: 4701047
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enzyme substitution in the treatment of pain in chronic pancreatitis. Significance of feedback regulation in pancreatic secretion].
    Adler G
    Dtsch Med Wochenschr; 1988 Jul; 113(26):1075-9. PubMed ID: 3289883
    [No Abstract]   [Full Text] [Related]  

  • 14. [The secretin-pancreozymin test in the diagnosis of pancreatic insufficiency].
    Rick W
    Internist (Berl); 1970 Mar; 11(3):110-7. PubMed ID: 4928886
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between pancreatic enzyme secretion and plasma concentration of human pancreatic polypeptide in health and in chronic pancreatitis.
    Owyang C; Scarpello JH; Vinik AI
    Gastroenterology; 1982 Jul; 83(1 Pt 1):55-62. PubMed ID: 6281125
    [No Abstract]   [Full Text] [Related]  

  • 16. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
    Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
    Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
    Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
    J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
    Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
    Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of neurotensin, cholecystokinin, and secretin in the stimulation of the exocrine pancreas in the dog.
    Baća I; Feurle GE; Haas M; Mernitz T
    Gastroenterology; 1983 Mar; 84(3):556-61. PubMed ID: 6295872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of anti-enzymatic therapy on the function of the pancreas in patients with chronic pancreatitis].
    Golubchenko OK
    Sov Med; 1971 May; 34(5):88-91. PubMed ID: 5316704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.